Niveau juridique : Union européenne
Texte de la question en date du 31-10-2018
On 25 July 2018, the Court of Justice of the European Union (Grand Chamber) handed down a judgment(1) stating that only organisms obtained by means of techniques or methods of mutagenesis which have conventionally been used are excluded from the scope of EU rules on GMOs. The judgment has caused concern among those in the European seed industry, who think that it could hamper their ability to innovate in selecting seeds and plants, especially because the vast majority of European SMEs cannot afford the regulatory costs of placing on the market an innovation that uses targeted genetic mutation techniques.
1. How is the Commission intending to bring the existing body of EC law into line with the ECJ’s judgment?
2. Has the Commission drawn up any guidelines for the European seed and plant industry on the future of the EU’s legislative framework for GMOs? Or is it intending to do so?
3.What impact does the Commission think that this judgment could have on innovation and development investment in the seed and plant industry?
En attente de réponse